Literature DB >> 21585201

A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases.

Xuelai Luo1, Yongxiang Liu, Stefan Kubicek, Johanna Myllyharju, Anthony Tumber, Stanley Ng, Ka Hing Che, Jessica Podoll, Tom D Heightman, Udo Oppermann, Stuart L Schreiber, Xiang Wang.   

Abstract

Histone methylations are important chromatin marks that regulate gene expression, genomic stability, DNA repair, and genomic imprinting. Histone demethylases are the most recent family of histone-modifying enzymes discovered. Here, we report the characterization of a small-molecule inhibitor of Jumonji C domain-containing histone demethylases. The inhibitor derives from a structure-based design and preferentially inhibits the subfamily of trimethyl lysine demethylases. Its methyl ester prodrug, methylstat, selectively inhibits Jumonji C domain-containing his-tone demethylases in cells and may be a useful small-molecule probe of chromatin and its role in epigenetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21585201      PMCID: PMC3133600          DOI: 10.1021/ja201597b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  44 in total

1.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.

Authors:  Karl Agger; Paul A C Cloos; Jesper Christensen; Diego Pasini; Simon Rose; Juri Rappsilber; Irina Issaeva; Eli Canaani; Anna Elisabetta Salcini; Kristian Helin
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

2.  Histone demethylation by a family of JmjC domain-containing proteins.

Authors:  Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang
Journal:  Nature       Date:  2005-12-18       Impact factor: 49.962

Review 3.  The future therapeutic potential of histone demethylases: A critical analysis.

Authors:  Gioacchino Natoli; Giuseppe Testa; Francesca De Santa
Journal:  Curr Opin Drug Discov Devel       Date:  2009-09

4.  Development of homogeneous luminescence assays for histone demethylase catalysis and binding.

Authors:  Akane Kawamura; Anthony Tumber; Nathan R Rose; Oliver N F King; Michelle Daniel; Udo Oppermann; Tom D Heightman; Christopher Schofield
Journal:  Anal Biochem       Date:  2010-05-21       Impact factor: 3.365

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  An Improved Synthesis of O-Benzoyl Protected Hydroxamates.

Authors:  Queenie Xianghong Wang; Jennifer King; Otto Phanstiel IV
Journal:  J Org Chem       Date:  1997-11-14       Impact factor: 4.354

7.  Structural insights into histone demethylation by JMJD2 family members.

Authors:  Zhongzhou Chen; Jianye Zang; Johnathan Whetstine; Xia Hong; Foteini Davrazou; Tatiana G Kutateladze; Michael Simpson; Qilong Mao; Cheol-Ho Pan; Shaodong Dai; James Hagman; Kirk Hansen; Yang Shi; Gongyi Zhang
Journal:  Cell       Date:  2006-05-04       Impact factor: 41.582

8.  Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Authors:  Shohei Hamada; Tae-Dong Kim; Takayoshi Suzuki; Yukihiro Itoh; Hiroki Tsumoto; Hidehiko Nakagawa; Ralf Janknecht; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2009-03-26       Impact factor: 2.823

9.  Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase.

Authors:  Jean-François Couture; Evys Collazo; Patricia A Ortiz-Tello; Joseph S Brunzelle; Raymond C Trievel
Journal:  Nat Struct Mol Biol       Date:  2007-06-24       Impact factor: 15.369

10.  PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression.

Authors:  Wen Liu; Bogdan Tanasa; Oksana V Tyurina; Tian Yuan Zhou; Reto Gassmann; Wei Ting Liu; Kenneth A Ohgi; Chris Benner; Ivan Garcia-Bassets; Aneel K Aggarwal; Arshad Desai; Pieter C Dorrestein; Christopher K Glass; Michael G Rosenfeld
Journal:  Nature       Date:  2010-07-11       Impact factor: 49.962

View more
  49 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.

Authors:  Nathan R Rose; Esther C Y Woon; Anthony Tumber; Louise J Walport; Rasheduzzaman Chowdhury; Xuan Shirley Li; Oliver N F King; Clarisse Lejeune; Stanley S Ng; Tobias Krojer; Mun Chiang Chan; Anna M Rydzik; Richard J Hopkinson; Ka Hing Che; Michelle Daniel; Claire Strain-Damerell; Carina Gileadi; Grazyna Kochan; Ivanhoe K H Leung; James Dunford; Kar Kheng Yeoh; Peter J Ratcliffe; Nicola Burgess-Brown; Frank von Delft; Susanne Muller; Brian Marsden; Paul E Brennan; Michael A McDonough; Udo Oppermann; Robert J Klose; Christopher J Schofield; Akane Kawamura
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

Review 3.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

4.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

Review 5.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

Review 6.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 7.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 8.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

9.  Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.

Authors:  Hyo Jeong Lee; Bo-Kyoung Kim; Kyoung Bin Yoon; Yong-Chul Kim; Sun-Young Han
Journal:  Invest New Drugs       Date:  2017-09-14       Impact factor: 3.850

Review 10.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.